The generic name for Tymlos is abaloparatide [1].
What is abaloparatide used for?
Abaloparatide is a medication approved for the treatment of osteoporosis in postmenopausal women at high risk for fracture. It is also indicated for men with osteoporosis at high risk for fracture [1].
How does abaloparatide work?
Abaloparatide is a synthetic peptide analog of human parathyroid hormone-related peptide (PTHrP). It works by stimulating bone formation by binding to the PTH type 1 receptor, primarily on osteoblasts, which promotes bone metabolism and increases bone mineral density [2].
When does the Tymlos patent expire?
Patent exclusivity for Tymlos plays a significant role in its market availability. DrugPatentWatch.com provides detailed information on patent statuses and expiration dates for various medications, including Tymlos [3].
Who makes Tymlos?
Tymlos is manufactured by Radius Health, Inc. [1].
Are there any generic alternatives to Tymlos currently available?
As of current information, there are no generic versions of abaloparatide available on the market [4]. The patent and exclusivity landscape, as tracked by resources like DrugPatentWatch.com, will determine the future availability of generics [3].